Erdogan issues new terror warning to Europe over conflict in Libya

Turkey's President Recep Tayyip Erdogan. (Reuters)
Short Url
Updated 19 January 2020

Erdogan issues new terror warning to Europe over conflict in Libya

  • Support government in Tripoli or Daesh will be unleashed again, Turkish president says

JEDDAH: Europe will face a new terrorist threat unless it steps up its support for the beleaguered Libyan government in Tripoli, Recep Tayyip Erdogan warned on Saturday.

The Turkish president spoke on the eve of a UN-sponsored summit of world leaders in Berlin aimed at resolving the conflict between Tripoli’s UN-backed Government of National Accord (GNA) and the Libya National Army (LNA) led by eastern military strongman Khalifa Haftar.

“Europe will encounter a fresh set of problems and threats if Libya’s legitimate government were to fall,” Erdogan said.

“Terrorist organizations such as Daesh and Al-Qaeda, which suffered a military defeat in Syria and Iraq, will find fertile ground to get back on their feet. “To leave Libya at the mercy of a warlord would be a mistake of historic proportions.”

Europe is unlikely to be impressed by Erdogan’s threats, analysts told Arab News. 

“Erdogan bets on military support for the government whereas Germany, in line with the UN, wants to implement the previously agreed arms embargo. This is where Europe and Turkey need to find a common line on Sunday,” said Mercator-IPC senior fellow Michael Thumann.


In a veiled rebuke to Erdogan, the UN special envoy for Libya said the involvement of foreign forces was making matters worse.

The GNA, led by Fayez Al-Sarraj, has been under siege by Haftar’s forces since April. Erdogan has sent Turkish military advisers and trainers to help Al-Sarraj’s forces, and has also redeployed up to 2,000 Turkish-backed mercenary fighters from the conflict in Syria.

In a veiled rebuke to Erdogan, the UN special envoy for Libya said the involvement of foreign forces was making matters worse.

“All foreign interference can provide some aspirin effect in the short term, but Libya needs all foreign interference to stop. That’s one of the objectives of this conference,” Ghassan Salame said.

The UN envoy also said he hoped but “could not predict” whether closed eastern oil ports would be reopened soon. 

Terminals across eastern and central Libya were shut on Friday by tribesmen allied to Haftar, in an attempt to choke off revenue to the government in Tripoli.

The closures are likely to be discussed at the summit. “If the thing is not solved between today and tomorrow I expect the issue to be raised, yes,” Salame said.

He said he hoped Haftar would consider extending a truce that has largely held for a week, despite the two sides failing to sign a deal at talks last week in Moscow.

The aims of Sunday’s summit are a permanent cease-fire, enforcement of a widely ignored UN arms embargo and a return to political efforts for peace.

Egypt sets virus vaccine target

Updated 32 min 44 sec ago

Egypt sets virus vaccine target

  • Volunteers will be closely monitored in order to take a second dose after 21 days

CAIRO: Assistant Health Minister and Coordinator of the Anti-COVID-19 Scientific Committee Ihab Kamal said that 842 people have volunteered in just one week to take part in Egypt’s coronavirus vaccine trials.

About 332 have been admitted in accordance with the health ministry’s requirements, which include being free from chronic disease.

Kamal said: “The number of volunteers until now is not low. We are working on raising the awareness of the citizens through various media platforms on the importance of the vaccine tests.” He added that the required number of volunteers is 6000.

He said the first two phases of the vaccine tests are complete and the third phase has begun. He added that volunteers are called for 21 days, pointing out that volunteers take a second dose in case they do not suffer any side effects. Kamal said the blood’s antibodies are measured throughout the year as part of the program.

Egyptian Minister of Health Hala Zayed announced on Thursday that she had launched the third and final phase of clinical trials on two vaccines developed by Egypt. She said the results of the two vaccine trials are positive so far.

Sources said that the Ministry of Health and the three centers taking part in the trials have received many applications. However, many of the applicants do not match the prerequisites, and therefore only 335 were accepted for the trials.

Zayed said in a press conference in Cairo that the current phase targets the participation of 6000 Egyptians. She said there are three places allocated for clinical trials.

Volunteers will be closely monitored in order to take a second dose after 21 days. After 45 days of the first dose, antibodies produced by the vaccine are measured to test their efficiency, Zayed said.

She said that national medical committees have been formed from civil and military bodies representing Egypt’s best medical experts.

She added that a committee will oversee conducting the clinical trials and that two vaccines out of seven have reached the third phase of clinical trials.

Zayed said that the first phase of the two vaccines included a test on a small group of 10 to 20 people with the aim of ensuring safety and also determining an appropriate dose. About 200 people took part in the second phase.

The third phase aimed included trials on 45,000 people from around the world, including 6,000 Egyptians.

The Ministry of Health and the company responsible for conducting the clinical trials explained the conditions that volunteers must follow to be eligible for tests.

They include an age bracket from 18 to 60 years old according to health condition. Registration must also be carried out using official documents. Volunteers must reside in Egypt or have valid residency documents during the trial period. Moreover, volunteers must sign an “informed consent” form prior to taking part in the trial.

There are a number of health conditions that prevent volunteers from taking part in the trials, including suffering from the symptoms of fever, dry cough, exhaustion and gonorrhea during the 14 days that precede the tests.